Replies to post #123941 on Biotech Values

[Regulardoc]

Correct. Did not mean to imply that TEVA was the only one raising prices, simply that the increased in revenues probably significantly influenced by pricing rather than increase market penetration or scripts alone.

The annual or semiannual increase in prices for all MS drugs has frankly been shameful!